Top

Published in:

01-08-2018 | What's New in Intensive Care

Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care

Authors: Ignacio Martin-Loeches, Robert Forster, Adriele Prina-Mello

Published in: Intensive Care Medicine | Issue 8/2018

Excerpt

Some techniques are only imagined, while others are at various stages of testing or actually being used today. Nanotechnology is expected to make diagnosis possible at the cellular and even the sub-cellular level. Currently, the comprehensive monitoring, control, construction, repair, defense and improvement of all human biologic systems, working from the molecular level, using engineered nano-devices and nanostructures are available in cancer. Given the current speed of innovation, it is difficult to anticipate what will be available or not in more than 30 years. A variety of emerging nanotechnologies are rapidly growing to a level of maturity; we believe that in 20–30 years they will be adopted as standard procedures in daily practice in intensive care units (ICU) [1]. Traditional medical devices attached to a patient are progressively evolving and being transformed by the introduction of nanoscience and nanotechnology into smart systems for continuous assessment for rapid critical care decision-making. …

Wong HR (2017) Intensive care medicine in 2050: precision medicine. Intensive Care Med. https://doi.org/10.1007/s00134-017-4727-y PubMedCrossRef

Martin-Loeches I, Perner A (2016) Focus on infection and sepsis in intensive care patients. Intensive Care Med 42:491–493. https://doi.org/10.1007/s00134-016-4234-6 CrossRefPubMed

Zilahi G, Artigas A, Martin-Loeches I (2016) What’s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care 6:96. https://doi.org/10.1186/s13613-016-0199-4 CrossRefPubMedPubMedCentral

Perner A, Rhodes A, Venkatesh B et al (2017) Sepsis: frontiers in supportive care, organisation and research. Intensive Care Med. https://doi.org/10.1007/s00134-017-4677-4 PubMedCentralCrossRefPubMed

Martin-Loeches I, Deja M, Koulenti D et al (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681. https://doi.org/10.1007/s00134-012-2808-5 CrossRefPubMed

Nwankire CE, Venkatanarayanan A, Glennon T et al (2015) Label-free impedance detection of cancer cells from whole blood on an integrated centrifugal microfluidic platform. Biosens Bioelectron 68:382–389. https://doi.org/10.1016/j.bios.2014.12.049 CrossRefPubMed

Singh M, Tong Y, Webster K et al (2017) 3D printed conformal microfluidics for isolation and profiling of biomarkers from whole organs. Lab Chip 17:2561–2571. https://doi.org/10.1039/c7lc00468k CrossRefPubMed

Beitler JR, Goligher EC, Schmidt M et al (2016) Personalized medicine for ARDS: the 2035 research agenda. Intensive Care Med 42:756–767. https://doi.org/10.1007/s00134-016-4331-6 CrossRefPubMedPubMedCentral

Sakr Y, Lobo SM, Moreno RP et al (2012) Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care 16:R222. https://doi.org/10.1186/cc11868 CrossRefPubMedPubMedCentral

10.

Bohmer N, Demarmels N, Tsolaki E et al (2017) Removal of cells from body fluids by magnetic separation in batch and continuous mode: influence of bead size, concentration, and contact time. ACS Appl Mater Interfaces 9:29571–29579. https://doi.org/10.1021/acsami.7b10140 CrossRefPubMed

11.

Basit H, Maher S, Forster RJ, Keyes TE (2017) Electrochemically triggered release of reagent to the proximal leaflet of a microcavity supported lipid bilayer. Langmuir 33:6691–6700. https://doi.org/10.1021/acs.langmuir.7b01069 CrossRefPubMed

12.

Gobbo OL, Sjaastad K, Radomski MW et al (2015) Magnetic nanoparticles in cancer theranostics. Theranostics 5:1249–1263. https://doi.org/10.7150/thno.11544 CrossRefPubMedPubMedCentral

13.

Sydney Gladman A, Matsumoto EA, Nuzzo RG et al (2016) Biomimetic 4D printing. Nat Mater 15:413–418CrossRefPubMed

14.

Toetsch S, Olwell P, Prina-Mello A, Volkov Y (2009) The evolution of chemotaxis assays from static models to physiologically relevant platforms. Integr Biol (Camb) 1:170–181. https://doi.org/10.1039/b814567a CrossRef

Title: Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care
Authors: Ignacio Martin-Loeches
Robert Forster
Adriele Prina-Mello
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 8/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-017-5002-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2018

Physical restraint: time to let go

Predictors of post-pneumonectomy respiratory failure and ARDS: usefulness of normalized pulmonary artery diameter

Predicting outcomes in very old ICU patients: time to focus on the past?

Intracranial pressure thresholds in severe traumatic brain injury: Pro

Sepsis: who will shoot first? Pharma or diagnostics?

Driving pressure in obese ventilated patients: another brick in the (chest) wall